Literature DB >> 28436345

Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience.

J van Os1, Y van der Steen1, Md A Islam2, S Gülöksüz1, B P Rutten1, C J Simons1.   

Abstract

BACKGROUND: The liability-threshold model of psychosis risk predicts stronger phenotypic manifestation of the polygenic risk score (PRS) in the healthy relatives of patients, as compared with healthy comparison subjects.
METHODS: First-degree relatives of patients with psychotic disorder (871 siblings and 812 parents) and healthy comparison subjects (n = 523) were interviewed three times in 6 years. Repeated measures of two psychosis phenotypes, the Community Assessment of Psychic Experiences (CAPE; self-report - subscales of positive, negative and depressive symptoms) and the Structured Interview for Schizotypy - Revised (SIS-R; clinical interview - subscales of positive and negative schizotypy), were examined for association with PRS. Interview-based lifetime rate of depressive and manic episodes were also examined, as was association with repeated measures of intelligence quotient (IQ).
RESULTS: In the relatives, PRS was associated with CAPE/SIS-R total score (respectively, B = 0.12, 95% CI 0.02-0.22 and B = 0.11, 95% CI 0.02-0.20), the SIS-R positive subscale (B = 0.16, 95% CI 0.04-0.28), the CAPE depression subscale (B = 0.21, 95% CI 0.07-0.34), any lifetime affective episode (OR 3.1, 95% CI 1.04-9.3), but not with IQ (B = -1.8, 95% CI -8.0 to 4.4). In the controls, similar associations were apparent between PRS on the one hand and SIS-R total score, SIS-R positive, SIS-R negative, any lifetime affective episode and, in contrast, lower IQ (B = -8.5, 95% CI -15.5 to -1.6).
CONCLUSIONS: In non-ill people, polygenic risk for psychotic disorder is expressed pleiotropically in the domain of neurodevelopment, emotion regulation and attribution of salience. In subjects at elevated genetic risk, emerging expression of neurodevelopmental alterations may create floor effects, obscuring genetic associations.

Entities:  

Keywords:  Depression; genetics; neurodevelopment; schizophrenia

Mesh:

Year:  2017        PMID: 28436345     DOI: 10.1017/S0033291717000915

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  22 in total

1.  Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome.

Authors:  Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

2.  Enhancing Psychosis-Spectrum Nosology Through an International Data Sharing Initiative.

Authors:  Anna R Docherty; Eduardo Fonseca-Pedrero; Martin Debbané; Raymond C K Chan; Richard J Linscott; Katherine G Jonas; David C Cicero; Melissa J Green; Leonard J Simms; Oliver Mason; David Watson; Ulrich Ettinger; Monika Waszczuk; Alexander Rapp; Phillip Grant; Roman Kotov; Colin G DeYoung; Camilo J Ruggero; Nicolas R Eaton; Robert F Krueger; Christopher Patrick; Christopher Hopwood; F Anthony O'Neill; David H Zald; Christopher C Conway; Daniel E Adkins; Irwin D Waldman; Jim van Os; Patrick F Sullivan; John S Anderson; Andrey A Shabalin; Scott R Sponheim; Stephan F Taylor; Rachel G Grazioplene; Silviu A Bacanu; Tim B Bigdeli; Corinna Haenschel; Dolores Malaspina; Diane C Gooding; Kristin Nicodemus; Frauke Schultze-Lutter; Neus Barrantes-Vidal; Christine Mohr; William T Carpenter; Alex S Cohen
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

Review 3.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

4.  Investigating genetic links between grapheme-colour synaesthesia and neuropsychiatric traits.

Authors:  Amanda K Tilot; Arianna Vino; Katerina S Kucera; Duncan A Carmichael; Loes van den Heuvel; Joery den Hoed; Anton V Sidoroff-Dorso; Archie Campbell; David J Porteous; Beate St Pourcain; Tessa M van Leeuwen; Jamie Ward; Romke Rouw; Julia Simner; Simon E Fisher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-10-21       Impact factor: 6.237

5.  Neuropsychiatric Genetics of Psychosis in the Mexican Population: A Genome-Wide Association Study Protocol for Schizophrenia, Schizoaffective, and Bipolar Disorder Patients and Controls.

Authors:  Beatriz Camarena; Elizabeth G Atkinson; Mark Baker; Claudia Becerra-Palars; Lori B Chibnik; Raúl Escamilla-Orozco; Joanna Jiménez-Pavón; Zan Koenig; Carla Márquez-Luna; Alicia R Martin; Ingrid Pamela Morales-Cedillo; Ana Maria Olivares; Hiram Ortega-Ortiz; Alejandra Monserrat Rodriguez-Ramírez; Ricardo Saracco-Alvarez; Rebecca E Basaldua; Brena F Sena; Karestan C Koenen
Journal:  Complex Psychiatry       Date:  2021-08-24

6.  Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Authors:  Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

7.  Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia.

Authors:  Lotta-Katrin Pries; Jim van Os; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Bochao D Lin; Kristel R van Eijk; Gunter Kenis; Alexander Richards; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz
Journal:  JAMA Psychiatry       Date:  2020-12-01       Impact factor: 21.596

8.  Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort.

Authors:  Jerome H Taylor; Nana Asabere; Monica E Calkins; Tyler M Moore; Sunny X Tang; Rose Mary Xavier; Alison K Merikangas; Daniel H Wolf; Laura Almasy; Ruben C Gur; Raquel E Gur
Journal:  Schizophr Res       Date:  2019-12-26       Impact factor: 4.939

9.  30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis.

Authors:  Robin M Murray; Vishal Bhavsar; Giada Tripoli; Oliver Howes
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

10.  A systematic review of genome-wide research on psychotic experiences and negative symptom traits: new revelations and implications for psychiatry.

Authors:  Angelica Ronald; Oliver Pain
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.